These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25048540)

  • 21. Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients.
    Kim JH; Ryu S; Nam HJ; Lim M; Baek JH; Joo YH; Kwon JS; Ha TH; Hong KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):75-9. PubMed ID: 22617280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia.
    Lindenmayer JP; Tedeschi F; Yusim A; Khan A; Kaushik S; Smith RC; Parakadavil M
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):185-92. PubMed ID: 22182455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Bae KY; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2010 May; 33(3):121-5. PubMed ID: 20502130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
    Li CH; Shi L; Zhan GL; Rao SZ; Zhang H
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2136-40. PubMed ID: 23893178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obsessive-compulsive symptoms in schizophrenia: prevalance and clinical correlates.
    Kayahan B; Ozturk O; Veznedaroglu B; Eraslan D
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):291-5. PubMed ID: 15896222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychopathology and quality of life among patients with comorbidity between schizophrenia spectrum disorder and obsessive-compulsive disorder: no evidence for a "schizo-obsessive" subtype.
    Frías A; Palma C; Farriols N; Salvador A; Bonet J; Bernáldez I
    Compr Psychiatry; 2014 Jul; 55(5):1165-73. PubMed ID: 24794642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis.
    Patel DD; Laws KR; Padhi A; Farrow JM; Mukhopadhaya K; Krishnaiah R; Fineberg NA
    Psychol Med; 2010 Jun; 40(6):921-33. PubMed ID: 19818202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorder.
    Faragian S; Fuchs C; Pashinian A; Weizman R; Weizman A; Poyurovsky M
    Psychiatry Res; 2012 May; 197(1-2):19-22. PubMed ID: 22436351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study.
    Bruno A; Pandolfo G; Cedro C; Gallo G; De Felice M; Zoccali RA; Muscatello MR
    Clin Neuropharmacol; 2016; 39(1):6-9. PubMed ID: 26757309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial.
    Mencacci C;
    Pharmacopsychiatry; 2012 Sep; 45(6):236-40. PubMed ID: 22592506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
    Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1470-7. PubMed ID: 17669573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of severe obsessive-compulsive disorder with schizotypal features: a pilot study.
    Huang LC; Hwang TJ; Huang GH; Hwu HG
    J Formos Med Assoc; 2011 Feb; 110(2):85-92. PubMed ID: 21377062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Obsessive-compulsive disorder and schizophrenia. A critical review].
    Frommhold K
    Fortschr Neurol Psychiatr; 2006 Jan; 74(1):32-48. PubMed ID: 16429333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obsessive compulsive symptoms are related to lower quality of life in patients with Schizophrenia.
    Üçok A; Kıvrak Tihan A; Karadayı G; Tükel R
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):243-7. PubMed ID: 25012893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD; Kerwin L; Saxena S; Bystritsky A
    Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open prospective study of ziprasidone in patients with schizophrenia with depressive symptoms: a multicenter study.
    Jung WY; Kim SG; Lee JS; Kang DH; Jung BJ; Shin DH; Lee YM; Choi SH
    Psychiatry Clin Neurosci; 2015 Jan; 69(1):43-8. PubMed ID: 24902868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.